Raphael Pharmaceutical Inc. (RAPH) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$1.28M | +15.8% |
| 2024 | -$1.52M | -13.0% |
| 2023 | -$1.34M | +60.0% |
| 2022 | -$3.36M | -106.6% |
| 2021 | -$1.62M | -126.3% |
| 2020 | -$718.0K | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$1.28M | +15.8% |
| 2024 | -$1.52M | -13.0% |
| 2023 | -$1.34M | +60.0% |
| 2022 | -$3.36M | -106.6% |
| 2021 | -$1.62M | -126.3% |
| 2020 | -$718.0K | — |